Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Funded Research Projects (Diagnostics for all Clinical Applications, Assay Formats and Disease Areas) -- Request for Proposals

Biomarker Factory, LLC

The Biomarker Factory is a company co-owned by Duke University and LabCorp. It was recently created to fund and manage the development and commercial launch of clinical diagnostics related to disease biology, treatment response and drug toxicity in cooperation with Duke investigators, LabCorp and other potential partners. The Biomarker Factory coordinates medical, scientific and commercial expertise related to biomarker development, biospecimen collections, clinical research, treatment practices, intellectual property, technology transfer, alliance management, market analysis, business development, manufacturing, regulatory clearance, reimbursement, health economics and healthcare policies by drawing resources and capabilities from LabCorp, Duke University and other organizations.

We are interested in diagnostics for all clinical applications, assay formats and disease areas. Examples include single biomarker assays, biomarker signatures, biomarker panels aligned with treatment guidelines, and companion diagnostics for drugs.

The Biomarker Factory is building a portfolio of funded research projects around proposals from Duke investigators. We will work with research teams to build programs funded against milestones through a design and review process between Duke investigators, The Biomarker Factory, LabCorp and other potential partners.

Proposals will be considered on a rolling basis for projects at all stages of development based on clear clinical value and a well defined development path against specific milestones. Funding levels will be commensurate with development requirements against milestones.

If you have ideas for a project, please return the provided proposal form to Terry Walker ( terry.walker@duke.edu ) as an initial step toward full proposal development.

Request for Proposals - May 2010 [pdf]
Biomarker Factory RFP - Proposal Form [MS Word]

Provide only non-confidential information in the proposal form and during initial discussions with The Biomarker Factory. Any questions about intellectual property or confidentiality should be discussed with Duke’s Office of Licensing and Ventures before disclosure to The Biomarker Factory.

Please share this announcement and related proposal form with other Duke colleagues and feel free to submit multiple proposals.

Deadline: Rolling .

Specialties

Medical - Basic Science

Medical - Translational

Medical

Medical - Clinical Science

Social Sciences

Eligibility Requirements

Sponsor Details

Sponsor Institute/Organizations: Biomarker Factory, LLC

Sponsor Type:

Address: NA

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity